Literature DB >> 22072845

Selection criteria for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in gastric cancer.

Ingmar Königsrainer1.   

Abstract

Peritoneal carcinomatosis in gastric cancer is associated with a dismal prognosis. Systemic chemotherapy is not effective because of the existence of a blood-peritoneal barrier. Cytoreductive surgery and intraperitoneal chemotherapy can improve survival and quality of life in selected patients. Patient selection for this multimodal approach is one of the most critical issues, and calls for interdisciplinary evaluation by radiologists, medical and surgical oncologists, and anaesthetists. This article sets forth criteria for selection of gastric cancer patients suffering from peritoneal carcinomatosis.

Entities:  

Keywords:  Cytoreductive surgery; Gastric cancer; Hyperthermic intraperitoneal chemotherapy; Peritoneal carcinomatosis; Selection criteria

Mesh：

Substances：

Year:  2011        PMID： 22072845      PMCID： PMC3208359          DOI： 10.3748/wjg.v17.i37.4153

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  19 in total

Review 1.  Cytoreduction and intraperitoneal chemotherapy for carcinomatosis from gastric cancer.

Authors:  Y Yonemura; E Bando; T Kawamura; H Ito; Y Endo; M Miura; K Kiyosaki; T Sasaki
Journal:  Cancer Treat Res       Date:  2007

2.  Multidisciplinary therapy for treatment of patients with peritoneal carcinomatosis from gastric cancer.

Authors:  Yutaka Yonemura; Ayman Elnemr; Yoshio Endou; Mitsumasa Hirano; Akiyoshi Mizumoto; Nobuyuki Takao; Masumi Ichinose; Masahiro Miura; Yan Li
Journal:  World J Gastrointest Oncol       Date:  2010-02-15

3.  A controlled clinical study of serosa-invasive gastric carcinoma patients who underwent surgery plus intraperitoneal hyperthermo-chemo-perfusion (IHCP).

Authors:  J Y Kim; H S Bae
Journal:  Gastric Cancer       Date:  2001       Impact factor: 7.370

4.  Phosphoglycerate kinase 1 promoting tumor progression and metastasis in gastric cancer - detected in a tumor mouse model using positron emission tomography/magnetic resonance imaging.

Authors:  Derek Zieker; Ingmar Königsrainer; Jürgen Weinreich; Stefan Beckert; Jörg Glatzle; Kay Nieselt; Sarah Bühler; Markus Löffler; Jochen Gaedcke; Hinnak Northoff; Julia G Mannheim; Stefan Wiehr; Bernd J Pichler; Claus von Weyhern; Björn L D M Brücher; Alfred Königsrainer
Journal:  Cell Physiol Biochem       Date:  2010-08-24

5.  Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Authors:  Eric Van Cutsem; Vladimir M Moiseyenko; Sergei Tjulandin; Alejandro Majlis; Manuel Constenla; Corrado Boni; Adriano Rodrigues; Miguel Fodor; Yee Chao; Edouard Voznyi; Marie-Laure Risse; Jaffer A Ajani
Journal:  J Clin Oncol       Date:  2006-11-01       Impact factor: 44.544

6.  Evaluation of preoperative computed tomography in estimating peritoneal cancer index in colorectal peritoneal carcinomatosis.

Authors:  Ju-Li Koh; Tristan D Yan; Derek Glenn; David L Morris
Journal:  Ann Surg Oncol       Date:  2008-12-03       Impact factor: 5.344

Review 7.  Effective therapy for peritoneal dissemination in gastric cancer.

Authors:  Yutaka Yonemura; Etsurou Bandou; Kazuo Kinoshita; Taiichi Kawamura; Shigeru Takahashi; Yoshio Endou; Takuma Sasaki
Journal:  Surg Oncol Clin N Am       Date:  2003-07       Impact factor: 3.495

8.  Phosphoglycerate kinase 1 a promoting enzyme for peritoneal dissemination in gastric cancer.

Authors:  Derek Zieker; Ingmar Königsrainer; Isabel Tritschler; Markus Löffler; Stefan Beckert; Frank Traub; Kay Nieselt; Sarah Bühler; Michael Weller; Jochen Gaedcke; Russell S Taichman; Hinnak Northoff; Björn L D M Brücher; Alfred Königsrainer
Journal:  Int J Cancer       Date:  2010-03-15       Impact factor: 7.396

9.  Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer.

Authors:  E Facchiano; S Scaringi; R Kianmanesh; J M Sabate; B Castel; Y Flamant; B Coffin; S Msika
Journal:  Eur J Surg Oncol       Date:  2007-07-20       Impact factor: 4.424

10.  (18)F-FDG-PET/CT to select patients with peritoneal carcinomatosis for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Authors:  Christina Pfannenberg; Ingmar Königsrainer; Philip Aschoff; Mehmet O Oksüz; Derek Zieker; Stefan Beckert; Stephan Symons; Kay Nieselt; Jörg Glatzle; Claus V Weyhern; Björn L Brücher; Claus D Claussen; Alfred Königsrainer
Journal:  Ann Surg Oncol       Date:  2009-02-28       Impact factor: 5.344
View more
  1 in total

Review 1.  Intraperitoneal chemotherapy from Armstrong to HIPEC: challenges and promise.

Authors:  Ramez N Eskander; James Cripe; Robert E Bristow
Journal:  Curr Treat Options Oncol       Date:  2014-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.